With NIH “Accountability” As Background, Advocates Support Budget Increases.
Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.
Bush Nominates VA Official For HHS Deputy Secretary.
Stronger Anti-Smoking Efforts Needed For Women, SG Says.
Meharry, Vanderbilt Win Grant For Research Collaboration.
FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.
US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.
Firm Begins Phase II Trial Of LDP-341 For Myeloma.
Faulding, NaPro In Agreement For Marketing Paclitaxel.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally
